Spark Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Spark Investment Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,780	Closed	-$22K	–	560
2019 Q4	$22K	Buy	+3,780	New	+$20.5K	﹤0.01%	534
2018 Q1	–	Sell	-14,060	Closed	-$527K	–	758
2017 Q4	$527K	Buy	+14,060	New	+$614K	0.03%	442
2016 Q4	–	Sell	-8,280	Closed	-$514K	–	910
2016 Q3	$514K	Buy	+8,280	New	+$585K	0.04%	480
2016 Q2	–	Sell	-40,020	Closed	-$2.56M	–	866
2016 Q1	$2.56M	Buy	40,020 +24,540	+159%	+$1.98M	0.26%	125
2015 Q4	$2.18M	Buy	+15,480	New	+$2.1M	0.28%	108

Other funds holding KDNY

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Spark Investment Management's KDNY Position: Q1 2020 in Review

Spark Investment Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2020, closing a stake of 3,780 shares — an estimated $22K sold.

Spark Investment Management first reported a position in KDNY in Q4 2015 and held it in 5 quarters. The position peaked at $2.56M in Q1 2016. 82 funds tracked by Wall St. Rank hold KDNY as of Q1 2020.

Spark Investment Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 3,780 Chinook Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $22K.
Spark Investment Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
Spark Investment Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2.56M in Q1 2016.
82 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.